| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/23/2013 | CN102309536B Ointment for treating frostbite and rahagades and preparation method of ointment |
| 01/23/2013 | CN102309452B Fluvastatin sodium liposome solid preparation |
| 01/23/2013 | CN102293752B Preparation method of chitosan-carried capsaicin microsphere as well as microsphere and application of microsphere in weight reduction and sugar reduction |
| 01/23/2013 | CN102274443B Compound Chinese medicinal microemulsion preparation capable of improving immunity |
| 01/23/2013 | CN102274181B Docetaxel lipid microsphere injection and preparation method thereof |
| 01/23/2013 | CN102228483B Freeze-dried preparation of xanthone anti-tumour medicine and preparation method thereof |
| 01/23/2013 | CN102210710B Bufo bufo gargarizans cantor skin extract gelskeleton sustained-release tablets and preparation method thereof |
| 01/23/2013 | CN102210645B Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof |
| 01/23/2013 | CN102205128B Antibacterial peptide preservative, antibacterial peptide preparation containing the same, and preparation method for the antibacterial peptide preparation |
| 01/23/2013 | CN102198087B Preservative-free ophthalmic in-situ gelling agent and preparation method thereof |
| 01/23/2013 | CN102188371B Ciclesonide nanoparticle aqueous solution and preparation method thereof |
| 01/23/2013 | CN102160855B Dex-ibuprofen sustained release tablets and preparation method thereof |
| 01/23/2013 | CN102139113B Novel pharmaceutical solubilization carrier and preparation method and application thereof |
| 01/23/2013 | CN102138895B Eyedrops containing fasudil hydrochloride and preparation method thereof |
| 01/23/2013 | CN102125535B Double-magnetic-response temperature-sensitive microcapsules and preparation method thereof |
| 01/23/2013 | CN102091051B Allopurinol dual-release preparation and preparation method thereof |
| 01/23/2013 | CN102078310B Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 01/23/2013 | CN102076340B Transdermal patch containing fentanyl or salt thereof |
| 01/23/2013 | CN102010513B Stable polysaccharide modified gelatin nano particle and preparation method and application thereof |
| 01/23/2013 | CN101987126B Medical burn antipyretic gauze and preparation thereof |
| 01/23/2013 | CN101967192B Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 01/23/2013 | CN101928355B Aminated alginic acid and preparation method thereof |
| 01/23/2013 | CN101921329B Alpha interferon mutant and polyethylene glycol derivative thereof |
| 01/23/2013 | CN101909606B Antipruritic sheet |
| 01/23/2013 | CN101904815B Ibuprofen microemulsion preparation and preparation method |
| 01/23/2013 | CN101888830B 透皮递送系统 Transdermal delivery systems |
| 01/23/2013 | CN101854940B Use of metal astringents for the treatment and prevention of hairy heel warts |
| 01/23/2013 | CN101829330B Calcium phosphate composite nanoparticle carrying genes as well as preparation method and application thereof |
| 01/23/2013 | CN101808628B Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient |
| 01/23/2013 | CN101791309B Oral solid preparation containing clopidogrel hydrogen sulfate |
| 01/23/2013 | CN101745114B Method for preparing glucose-sensitive insulin controlled-release biological material |
| 01/23/2013 | CN101721431B Compound nano pearl starch ball and production process thereof |
| 01/23/2013 | CN101709073B Nucleotide phospholipid molecule and lipidosome and preparation method and application thereof |
| 01/23/2013 | CN101703690B Medicament for treating metrorrhagia and metrostaxis, hematemesis, hematochezia and traumatic hemorrhage and preparation method thereof |
| 01/23/2013 | CN101698089B Traditional Chinese medicine volatile oil inclusion complex and preparation method thereof |
| 01/23/2013 | CN101687049B Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 01/23/2013 | CN101541311B Granular preparation prevented from caking |
| 01/23/2013 | CN101528263B Conjugates for innate immunotherapy of cancer |
| 01/23/2013 | CN101511370B Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 01/23/2013 | CN101507717B Composite tablet capable of treating peptic ulcer and preparation method thereof |
| 01/23/2013 | CN101485629B Drug delivery system and preparation method thereof |
| 01/23/2013 | CN101478888B Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations |
| 01/23/2013 | CN101422615B Oridonin polymer micelle administration preparation and preparation method thereof |
| 01/23/2013 | CN101417005B Gentian bitterness concealing technique in oral liquid |
| 01/23/2013 | CN101360513B Biodegradable and thermosensitive poly(organophosphazene) hydrogel, preparation method thereof and use thereof |
| 01/23/2013 | CN101314045B Sulphur butyl ether-beta-cyclodextrin clathrate compound of cinnarizine, formulated product and preparation method thereof |
| 01/23/2013 | CN101244044B Entecavir dispersible tablet and preparation thereof |
| 01/23/2013 | CN101171039B 酶和受体调节 Enzymes and receptor modulator |
| 01/23/2013 | CN101164620B External preparation for skin |
| 01/23/2013 | CN101107015B 乳腺炎用注入剂 Mastitis with implants |
| 01/22/2013 | US8357789 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/22/2013 | US8357722 Lipids, lipid complexes and use thereof |
| 01/22/2013 | US8357506 Method of identifying improved conjugates of biologically active compounds |
| 01/22/2013 | US8357415 Method for producing orally administrable edible agent of aggregated subtance-containing laminate film form and orally administrable edible agent of aggregated substance-containing laminate film form |
| 01/22/2013 | US8357405 Nut skin products and methods of use thereof |
| 01/22/2013 | US8357402 Flowable wound matrix and its preparation and use |
| 01/22/2013 | US8357401 Stable formulations for lyophilizing therapeutic particles |
| 01/22/2013 | US8357400 Stimuli-responsive systems for controlled drug delivery |
| 01/22/2013 | US8357399 Tamper-resistant oral opioid agonist formulations |
| 01/22/2013 | US8357377 Drug carriers; such as nucleic acids; sustained release; biocompatibility polymer |
| 01/22/2013 | US8357374 Conjugates of synthetic TLR agonists and uses therefor |
| 01/22/2013 | US8357357 3.2.1-bicyclo-octene and -octane compounds |
| 01/22/2013 | CA2689101C Modifying drug release in suspensions of ionic resin systems |
| 01/22/2013 | CA2566713C Wound healing polymer compositions and methods for use thereof |
| 01/22/2013 | CA2560241C Carbohydrate-derivatized liposomes for targeting cellular carbohydrate recognition domains of ctl/ctld lectins, and intracellular delivery of therapeutically active compounds |
| 01/22/2013 | CA2537250C Topical preparations comprising a hydrophilic carrier and a silicone matrix |
| 01/22/2013 | CA2458794C Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 01/22/2013 | CA2455638C Peptide-based multimeric targeted contrast agents |
| 01/22/2013 | CA2452582C G-csf conjugates |
| 01/22/2013 | CA2448607C Colloidal metal compositions and methods |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/22/2013 | CA2400610C Endoparasiticidal compositions comprising a cyclic depsipeptide |
| 01/22/2013 | CA2346122C Stabilized bioactive peptides and methods of identification, synthesis and use |
| 01/22/2013 | CA2342732C Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin |
| 01/22/2013 | CA2290078C Erysipelothrix rhusiopathiae antigens and vaccine compositions |
| 01/19/2013 | WO2013012430A1 Dhea bioadhesive controlled release gel |
| 01/19/2013 | CA2795991A1 Dhea bioadhesive controlled release gel |
| 01/17/2013 | WO2013010087A1 Poly((lactic-co-glycolic acid)-b-lysine) and process for synthesizing a block copolymer of plga {poly(lactic-co-glycolic acid)} and pll (poly-e-cbz-l-lysine) |
| 01/17/2013 | WO2013010032A1 Gel compositions of oxymetazoline and methods of use |
| 01/17/2013 | WO2013009826A1 Conjugating amines |
| 01/17/2013 | WO2013009790A2 A heat stable oxygen carrier-containing pharmaceutical composition for different treatment applications |
| 01/17/2013 | WO2013009701A2 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders |
| 01/17/2013 | WO2013009564A1 Tyrosine ligation process |
| 01/17/2013 | WO2013009142A2 Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same |
| 01/17/2013 | WO2013009015A1 Novel production method for a composite powder comprising an ultraviolet blocker surface-treated layer |
| 01/17/2013 | WO2013008909A1 Loxoprofen sodium-containing adhesive patch for external applications |
| 01/17/2013 | WO2013008875A1 Flavor-improving method |
| 01/17/2013 | WO2013008716A1 Aqueous ophthalmic composition |
| 01/17/2013 | WO2013008715A1 Aqueous ophthalmic composition |
| 01/17/2013 | WO2013008714A1 Ophthalmic aqueous composition |
| 01/17/2013 | WO2013007762A1 Combination of an anticoagulant and avidin useful in surgical intervention and clinical procedure |
| 01/17/2013 | WO2013007365A1 Gel for use in a wound treatment composition |
| 01/17/2013 | WO2013006978A1 Neuroprotective pepties that inhbit interaction between palmitoyl acyl transferase zinc- finger dhhc type containing 17 (zd17) and c-jun n-terminal kinase (jnk) |
| 01/17/2013 | WO2013006972A1 Novel anti-cancer isocarbostyril alkaloid conjugates |
| 01/17/2013 | WO2012160450A3 Modular transport platform for targeted delivery of therapeutic agents |
| 01/17/2013 | WO2012160180A3 Pharmaceutical composition for administration to nails |
| 01/17/2013 | WO2012160179A3 Topical pharmaceutical composition based on semifluorinated alkanes |
| 01/17/2013 | WO2012159077A3 Multiple dosing regimen oral drug delivery platform |
| 01/17/2013 | WO2012158312A9 Skin and hair regeneration using polysaccharide-based hydrogels |
| 01/17/2013 | WO2012151039A3 Compositions and methods for detecting mycobacterium |